Linklaters focuses on supporting national and cross-border transactions and follows a multidisciplinary approach, including cross-border competencies thanks to the international network. Among the client roster are companies from the pharmaceutical, biotechnology, medical device and healthcare services sectors, which benefit from Tim Johannsen-Roth‘s in-depth corporate law expertise, while Jana Hager covers regulatory aspects both in the context of transactions as well as in connection with medical devices and pharmaceuticals. Julia Schönbohm complements this with expertise in patent law and litigation.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Very good knowledge of the regulatory environment.'
Work highlights
- Advising Stada on the acquisition of a portfolio of consumer health brands from Sanofi.
- Advising Theramex on the acquisition of the menopause drugs Duphaston and Femoston from Viatris.
- Advising Fresenius SE & Co. KGaA and its committees on the deconsolidation of its subsidiary Fresenius Medical Care AG & Co. KGaA by way of a change of legal form into a stock corporation.